Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pharmacol.

Sec. Drugs Outcomes Research and Policies

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1558515

Physician self-reported factors driving clinical decision-making in management of patients with T2D and ASCVD/high risk of ASCVD across the Middle East and Africa: a cross-sectional study

Provisionally accepted
Sam  SalekSam Salek1*Hani  SabbourHani Sabbour2Naji  AlamuddinNaji Alamuddin3Fatheya  AlawadiFatheya Alawadi4Hessa  AlkandariHessa Alkandari5,6Wael  AlmahmeedWael Almahmeed2Samir  H Assaad-KhalilSamir H Assaad-Khalil7Emel  Mashaki CeyhanEmel Mashaki Ceyhan8Jihad  HaddadJihad Haddad9Landman  LombardLandman Lombard10Mary  NgomeMary Ngome11Rayaz  A MalikRayaz A Malik12Gourav  YadavGourav Yadav11
  • 1Professor of Pharmacoepidemiology, University of Hertfordshire, Hatfield, United Kingdom
  • 2Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, Abu Dhabi, United Arab Emirates
  • 3Royal College of Surgeons in Ireland (Bahrain), Al Muharraq, Bahrain
  • 4Endocrine Department, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates
  • 5Department of Pediatrics, Farwaniya Hospital, Kuwait city, Kuwait
  • 6Department of Population Health, Dasman Diabetes Institute, Kuwait City, Kuwait
  • 7Unit of Diabetes, Lipidology & Metabolism; Department of Internal Medicine/Alexandria Faculty of Medicine, Alexandria University,, Egypt, Egypt
  • 8Novo Nordisk A/S, Søborg, Denmark
  • 9Endocrinology Section, Bader Medical Complex, Amman, Jordan
  • 10Cape Town Medical Research Centre, Cape Town, South Africa
  • 11Novo Nordisk Saglik Urunleri Tic Ltd Sti, Istanbul, Türkiye
  • 12Department of Medicine, Weill Cornell Medicine-Qatar, Education City, Doha, Qatar

The final, formatted version of the article will be published soon.

Aims: To explore factors influencing the clinical decision-making of physicians treating patients with type 2 diabetes (T2D) and high risk of atherosclerotic cardiovascular disease (ASCVD) across seven Middle Eastern and African countries.Methods: Cross-sectional, anonymous online study of self-reported factors driving clinical decisionmaking for the management of T2D based on agreement with statements using a five-point Likert scale among physicians (n=385) in Bahrain, Egypt, Jordan, Kuwait, Qatar, South Africa, and UAE between June 13 and October 1, 2022.Results: From a selection of patient factors, physicians were most likely to agree that treatment adherence/compliance (92%), safety concerns (92%), and impact on health-related quality of life (88%) influenced their decision-making. Most physicians agreed that availability of treatment (87%) was a practice setting factor that influenced their decision-making. The top three physician factors influencing clinical decision-making included continuous medical education (96%), medical knowledge (96%), and international clinical guidelines (95%). Most physicians agreed that improved communication skills of physicians (97%), coaching and question prompts for patients (91%), and patient decision aids (87%) could improve shared decision-making.Various patient, practice, and physician factors influenced physicians' management of their patients with T2D. Physicians believed improving their communication skills could improve shared decision-making.

Keywords: Atherosclerotic cardiovascular disease, clinical decision-making, Heart disease risk factors, Public Health Systems Research, type 2 diabetes

Received: 10 Jan 2025; Accepted: 14 Aug 2025.

Copyright: © 2025 Salek, Sabbour, Alamuddin, Alawadi, Alkandari, Almahmeed, Assaad-Khalil, Ceyhan, Haddad, Lombard, Ngome, Malik and Yadav. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Sam Salek, Professor of Pharmacoepidemiology, University of Hertfordshire, Hatfield, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.